Translating colorectal cancer prevention through the guanylyl cyclase C signaling axis

Linaclotide, Novel Therapy for the Treatment of Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome

(2013) Maria I. Vazquez-Roque et al.   ADVANCES IN THERAPY

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Molecular mechanisms of chemopreventive phytochemicals against gastroenterological cancer development

(2013) Min-Yu Chung   WORLD JOURNAL OF GASTROENTEROLOGY

Colonoscopy for Colorectal Cancer Screening

(2013) Patrick E. Young et al.   Journal of Cancer

Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints

(2012) E. M. M. Quigley et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety

(2012) William D Chey et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation

(2012) Satish Rao et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A review of the clinical efficacy of linaclotide in irritable bowel syndrome with constipation

(2012) Jeffrey M. Johnston et al.   CURRENT MEDICAL RESEARCH AND OPINION

Translating cancer 'omics' to improved outcomes

(2012) E. A. Vucic et al.   GENOME RESEARCH

Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib

(2012) Jeffrey A. Sosman et al.   NEW ENGLAND JOURNAL OF MEDICINE

GUCY2C Opposes Systemic Genotoxic Tumorigenesis by Regulating AKT-Dependent Intestinal Barrier Integrity

(2012) Jieru Egeria Lin et al.   PLoS One

Body Size and Colorectal Cancer Risk After 16.3 Years of Follow-up: An Analysis From the Netherlands Cohort Study

(2011) L. A. E. Hughes et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Non-Steroidal Anti-Inflammatory Drugs and Colorectal Cancer Risk in a Large, Prospective Cohort

(2011) Elizabeth H Ruder et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Molecular Genetics of Colorectal Cancer

(2011) Eric R. Fearon   Annual Review of Pathology-Mechanisms of Disease

Pharmacology and cellular/molecular mechanisms of action of aspirin and Non-aspirin NSAIDs in colorectal cancer

(2011) Karsten Schrör   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Regulatory Approval of Cancer Risk-Reducing (Chemopreventive) Drugs: Moving What We Have Learned into the Clinic

(2011) F. L. Meyskens et al.   Cancer Prevention Research

Projections of the Cost of Cancer Care in the United States: 2010-2020

(2011) A. B. Mariotto et al.   JNCI-Journal of the National Cancer Institute

Predictive, personalized, preventive, participatory (P4) cancer medicine

(2011) Leroy Hood et al.   Nature Reviews Clinical Oncology

Loss of Guanylyl Cyclase C (GCC) Signaling Leads to Dysfunctional Intestinal Barrier

(2011) Xiaonan Han et al.   PLoS One

Linaclotide, a synthetic guanylate cyclase C agonist, for the treatment of functional gastrointestinal disorders associated with constipation

(2011) Maria Vazquez Roque et al.   Expert Review of Gastroenterology & Hepatology

Deconstructing the Drug Development Process: The New Face of Innovation

(2010) K I Kaitin   CLINICAL PHARMACOLOGY & THERAPEUTICS

Linaclotide Improves Abdominal Pain and Bowel Habits in a Phase IIb Study of Patients With Irritable Bowel Syndrome With Constipation

(2010) Jeffrey M. Johnston et al.   GASTROENTEROLOGY

Inflammation and Colon Cancer

(2010) Janoš Terzić et al.   GASTROENTEROLOGY

Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract

(2010) Alexander P. Bryant et al.   LIFE SCIENCES

Microsatellite instability in colorectal cancer—the stable evidence

(2010) Eduardo Vilar et al.   Nature Reviews Clinical Oncology

American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008

(2009) Oralia Garcia Dominic et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Nonsteroidal Antiinflammatory Drugs and Cyclooxygenase Inhibition in the Gastrointestinal Tract: A Trip From Peptic Ulcer to Colon Cancer

(2009) Angel Lanas   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

NO-NSAIDs: Gastric-sparing nitric oxide-releasable prodrugs of non-steroidal anti-inflammatory drugs

(2009) Kumar V.S. Nemmani et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Guanylyl Cyclase C Prevents Colon Cancer Metastasis by Regulating Tumor Epithelial Cell Matrix Metalloproteinase-9

(2009) W. J. Lubbe et al.   CANCER RESEARCH

GCC signaling in colorectal cancer: Is colorectal cancer a paracrine deficiency syndrome?

(2009) P. Li et al.   DRUG NEWS & PERSPECTIVES

Small-molecule inhibitors of the human epidermal receptor family

(2009) Corey A Carter et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

The Hormone Receptor GUCY2C Suppresses Intestinal Tumor Formation by Inhibiting AKT Signaling

(2009) Jieru Egeria Lin et al.   GASTROENTEROLOGY

The Scientific Foundation for Personal Genomics: Recommendations from a National Institutes of Health–Centers for Disease Control and Prevention Multidisciplinary Workshop

(2009) Muin J Khoury et al.   GENETICS IN MEDICINE

Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk Factors

(2009) Fatima Haggar et al.   Clinics in Colon and Rectal Surgery

High frequency of early colorectal cancer in inflammatory bowel disease

(2008) M W M D Lutgens et al.   GUT